Subscribe now

For our monthly insights digest

×

Name

Company

Email

Yes, I would like to receive the personalized DKSH newsletter with updates about the company via email which includes the use of standard technologies to measure the interactions with the newsletter (e.g. clicked links). I can withdraw the consent any time. For more information, please read the Privacy Policy.

Click here for the Privacy Statement.

Invalid Captcha

Thank you for subscribing to DKSH insights. You will receive an email confirming your subscription shortly.

Healthway Medical Overcomes Demanding Cold Chain Requirements to Distribute COVID-19 Vaccines in Singapore

Amid the increased demand by the population for an alternative to mRNA vaccines, stringent cold chain requirements, and the Special Access Route established by the Health Sciences Authority, Healthway Medical managed to bring the Sinopharm SARS-CoV-2 vaccine into Singapore.

Back

Share:

Business Units

Business Lines

Pharmaceuticals

Services

Distribution and logistics

Markets

Healthway Medical Group is one of the leading private medical groups in Singapore. With over 100 clinics and medical centers, it offers comprehensive services including health screening, adult specialists, baby and child specialists, dental services, and allied healthcare services. During the COVID-19 pandemic, it supplied the Sinopharm COVID-19 vaccine across its network of general practitioner clinics in Singapore.

Healthway Medical Overcomes Demanding Cold Chain Requirements To Distribute COVID-19 Vaccines in Singapore

Challenge

The emergence of the pandemic meant that there was an increased demand in Singapore for cold chain facilities to store and manage the vaccines and along with it, the delivery and, logistics required to support these facilities.

Due to the short timeframe of delivery and quick turnaround services, the customer needed a cold chain business partner with the available capacity, resources, and capabilities to manage the cold chain requirements for the Sinopharm vaccine.

Approach

The priority for us was to plan and manage a three-hour delivery window period for the lifesaving and COVID-19 related diagnostic products. To achieve this, we adjusted the team’s manpower and logistics schedule to cope with the increase of around 30 percent in cold chain deliveries.

We also added another 50 percent more temperature loggers and invested in new radio frequency systems for tracking, monitoring, and managing the internal logistics movement of the products.

Result

We were able to help Healthway Medical Group manage the vaccines’ logistics and deliveries to all their locations and clinics. The successful rollout of the vaccines meant that the population was able to receive their vaccination safely and on time.

Related stories

DKSH’s distribution center in Singapore quickly adjusts to COVID-19 cold chain needs

DKSH’s distribution center in Singapore quickly adjusts to COVID-19 cold chain needs

Alcon eyes clearer and faster delivery systems in Singapore

Alcon eyes clearer and faster delivery systems in Singapore

Mapping growth opportunities for a pharma company new to Asia

Mapping growth opportunities for a pharma company new to Asia

3M successfully relocates to new warehouse amid COVID-19 in Thailand

3M successfully relocates to new warehouse amid COVID-19 in Thailand

Tosoh continues to achieve sales targets in challenging Vietnam market

Tosoh continues to achieve sales targets in challenging Vietnam market

Analgesic Medicine Achieves Sales Growth Despite Pandemic Challenges

Analgesic Medicine Achieves Sales Growth Despite Pandemic Challenges